Stay updated on Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial
Sign up to get notified when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.

Latest updates to the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page
- Check3 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a new build/patch of the page rather than substantive content changes.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedUpdates the ClinicalTrials.gov page’s revision/version indicator from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.0%

- Check74 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check96 days agoChange DetectedFallopian tube cancer is now listed as a condition on the page, and the page revision updated to v3.4.2 (replacing v3.4.1).SummaryDifference0.1%

- Check103 days agoChange DetectedAdded 'Primary peritoneal carcinoma' to the conditions/terms and introduced a resources entry for the Genetic and Rare Diseases Information Center. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.2%

Stay in the know with updates to Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.